These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 2469544)

  • 1. Carboplatin and etoposide pharmacokinetics in patients with testicular teratoma.
    Newell DR; Eeles RA; Gumbrell LA; Boxall FE; Horwich A; Calvert AH
    Cancer Chemother Pharmacol; 1989; 23(6):367-72. PubMed ID: 2469544
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The optimisation of carboplatin dose in carboplatin, etoposide and bleomycin combination chemotherapy for good prognosis metastatic nonseminomatous germ cell tumours of the testis.
    Childs WJ; Nicholls EJ; Horwich A
    Ann Oncol; 1992 Apr; 3(4):291-6. PubMed ID: 1382552
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Carboplatin dose in combination chemotherapy for testicular cancer.
    Harland SJ; Gumbrell LA; Horwich A
    Eur J Cancer; 1991; 27(6):691-5. PubMed ID: 1712607
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Carboplatin pharmacokinetics in young children with brain tumors.
    Tonda ME; Heideman RL; Petros WP; Friedman HS; Murry DJ; Rodman JH
    Cancer Chemother Pharmacol; 1996; 38(5):395-400. PubMed ID: 8765431
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Population pharmacokinetics of carboplatin, etoposide and melphalan in children: a re-evaluation of paediatric dosing formulas for carboplatin in patients with normal or mild impairment of renal function.
    Duong JK; Veal GJ; Nath CE; Shaw PJ; Errington J; Ladenstein R; Boddy AV
    Br J Clin Pharmacol; 2019 Jan; 85(1):136-146. PubMed ID: 30261554
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Carboplatin dosage: prospective evaluation of a simple formula based on renal function.
    Calvert AH; Newell DR; Gumbrell LA; O'Reilly S; Burnell M; Boxall FE; Siddik ZH; Judson IR; Gore ME; Wiltshaw E
    J Clin Oncol; 1989 Nov; 7(11):1748-56. PubMed ID: 2681557
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Randomized trial of bleomycin, etoposide, and cisplatin compared with bleomycin, etoposide, and carboplatin in good-prognosis metastatic nonseminomatous germ cell cancer: a Multiinstitutional Medical Research Council/European Organization for Research and Treatment of Cancer Trial.
    Horwich A; Sleijfer DT; Fosså SD; Kaye SB; Oliver RT; Cullen MH; Mead GM; de Wit R; de Mulder PH; Dearnaley DP; Cook PA; Sylvester RJ; Stenning SP
    J Clin Oncol; 1997 May; 15(5):1844-52. PubMed ID: 9164194
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low dose bleomycin with etoposide and cisplatin for metastatic testicular teratoma.
    Coleman RE; Whillis D; Howard GC; Taylor RE; Cornbleet MA
    Br J Urol; 1991 Sep; 68(3):296-300. PubMed ID: 1717098
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics of high-dose etoposide after short-term infusion.
    Köhl P; Köppler H; Schmidt L; Fritsch HW; Holz J; Pflüger KH; Jungclas H
    Cancer Chemother Pharmacol; 1992; 29(4):316-20. PubMed ID: 1537079
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical pharmacokinetics and dose optimisation of carboplatin.
    Duffull SB; Robinson BA
    Clin Pharmacokinet; 1997 Sep; 33(3):161-83. PubMed ID: 9314610
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phase I trial with pharmacokinetic analyses of high-dose carboplatin, etoposide, and cyclophosphamide with autologous bone marrow transplantation in patients with refractory germ cell tumors.
    Motzer RJ; Gulati SC; Tong WP; Menendez-Botet C; Lyn P; Mazumdar M; Vlamis V; Lin S; Bosl GJ
    Cancer Res; 1993 Aug; 53(16):3730-5. PubMed ID: 8393380
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A limited sampling method for estimation of the etoposide area under the curve.
    Strömgren AS; Sørensen BT; Jakobsen P; Jakobsen A
    Cancer Chemother Pharmacol; 1993; 32(3):226-30. PubMed ID: 7684658
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Testicular function in patients with testicular cancer treated with bleomycin-etoposide-carboplatin (BEC(90)) combination chemotherapy.
    Pectasides D; Pectasides M; Farmakis D; Nikolaou M; Koumpou M; Kostopoulou V; Mylonakis N
    Eur Urol; 2004 Feb; 45(2):187-93. PubMed ID: 14734005
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Etoposide phosphate infusion with therapeutic drug monitoring in combination with carboplatin dosed by area under the curve: a cancer research campaign phase I/II committee study.
    Porter D; Boddy A; Thomas H; Lind M; Newell D; Calvert AH; Robson L; Brampton M; Abrahamsen D; Winograd B
    Semin Oncol; 1996 Dec; 23(6 Suppl 13):34-44. PubMed ID: 8996574
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phase I study of escalating targeted doses of carboplatin combined with ifosfamide and etoposide in treatment of newly diagnosed pediatric solid tumors.
    Marina NM; Rodman JH; Murry DJ; Shema SJ; Bowman LC; Jones DP; Furman W; Meyer WH; Pratt CB
    J Natl Cancer Inst; 1994 Apr; 86(7):544-8. PubMed ID: 8133538
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Chemotherapy in hemodialysis patient with metastatic testicular cancer; pharmacokinetics of etoposide and cisplatin].
    Kamizuru M; Iwata H; Terada T; Kato S; Yoshihara H
    Nihon Hinyokika Gakkai Zasshi; 2000; 91(7-8):599-603. PubMed ID: 10965746
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics of carboplatin administered with lobradimil to pediatric patients with brain tumors.
    Warren K; Gervais A; Aikin A; Egorin M; Balis FM
    Cancer Chemother Pharmacol; 2004 Sep; 54(3):206-12. PubMed ID: 15156345
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Etoposide pharmacokinetics in children: the development and prospective validation of a dosing equation.
    Lowis SP; Pearson AD; Newell DR; Cole M
    Cancer Res; 1993 Oct; 53(20):4881-9. PubMed ID: 8402676
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effectiveness of carboplatin, etoposide, and bleomycin combination chemotherapy in good-prognosis metastatic testicular nonseminomatous germ cell tumors.
    Horwich A; Dearnaley DP; Nicholls J; Jay G; Mason M; Harland S; Peckham MJ; Hendry WF
    J Clin Oncol; 1991 Jan; 9(1):62-9. PubMed ID: 1702147
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combination chemotherapy with bleomycin, etoposide and cisplatin (BEP) for metastatic testicular teratoma: long-term follow-up.
    Dearnaley DP; Horwich A; A'Hern R; Nicholls J; Jay G; Hendry WF; Peckham MJ
    Eur J Cancer; 1991; 27(6):684-91. PubMed ID: 1712606
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.